Latest Neuraminidase inhibitors Stories
Federal health officials in the US have issued a consumer warning about fraudulent products making unsubstantiated claims that they can treat, cure, or prevent the flu virus.
An antiviral medication that can chemically slow the spread of influenza virus between the body's cells, has been approved by the US Food and Drug Administration (FDA) for use in infants as young as 14 days old, the agency announced on Friday.
Computer chips of a type more commonly found in games consoles have been used by scientists at the University of Bristol to reveal how the flu virus resists anti-flu drugs such as Relenza and Tamiflu.
The full clinical study reports of drugs that have been authorized for use in patients should be made publicly available in order to allow independent re-analysis of the benefits and risks of such drugs.
A group of independent scientists has challenged the manufacturers of the anti-flu treatment Tamiflu to substantiate the treatment’s effectiveness by releasing previously withheld research data.
Incomplete availability of data has hampered a thorough assessment of the evidence for using the anti-influenza drug oseltamivir, a Cochrane Review has found.
SAN DIEGO, Aug.
More Images (1 images) »